Lindsay Brown
Directeur/Membre du Conseil chez Priority Processing Systems Pty Ltd.
Postes actifs de Lindsay Brown
Sociétés | Poste | Début | Fin |
---|---|---|---|
Priority Processing Systems Pty Ltd.
Priority Processing Systems Pty Ltd. Regional BanksFinance Part of Spenda Ltd., Priority Processing Systems Pty Ltd. offers financial transaction based services to consumers and retailers. Priority Processing Systems was acquired by Motopia Ltd. on March 07, 2013 for $1.03 million. | Directeur/Membre du Conseil | - | - |
CU2 Global Pty Ltd.
CU2 Global Pty Ltd. Packaged SoftwareTechnology Services Part of Spenda Ltd., CU2 Global Pty Ltd. is an Australian company that helps organizations address and manage the complexity of a changing digital world. The company is based in Auburn, Australia. CU2 Global has been providing legacy application migration services to a clientele for over a decade. CU2 Global was acquired by Motopia Ltd. on November 07, 2014 for $0.09 million. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Lindsay Brown
Anciens postes connus de Lindsay Brown
Sociétés | Poste | Début | Fin |
---|---|---|---|
Motopia Ltd.
Motopia Ltd. Packaged SoftwareTechnology Services Motopia Ltd. owns and operates technology assets. It operates through the following business segments: System Migration and App Development. The System Migration engages in the specialized or custom system migration technologies. The App Development includes development of mobile and tablet applications. The company was founded on December 18, 2001 and is headquartered in South Yarra, Australia. | Directeur/Membre du Conseil | 08/03/2013 | 15/08/2014 |
Elk OrthoBiologics Ltd.
Elk OrthoBiologics Ltd. BiotechnologyHealth Technology Elk OrthoBiologics Ltd. is an Australian biotechnology company developing a minimally invasive biologic therapy for repairing aseptically loosened hip and knee prosthetic implants. It offers Gene Directed Enzyme Prodrug Therapy (GDEPT), a technology where a short acting gene therapy is used to convert a small molecule prodrug into an active drug within a target tissue. It is also a onetime treatment designed to destroy an unwanted tissue. The company is headquartered in Hawthorn East, the United Kingdom. | Président | - | - |
Statistiques
Internationale
Australie | 5 |
Opérationnelle
Director/Board Member | 3 |
Chairman | 1 |
Sectorielle
Technology Services | 3 |
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Motopia Ltd.
Motopia Ltd. Packaged SoftwareTechnology Services Motopia Ltd. owns and operates technology assets. It operates through the following business segments: System Migration and App Development. The System Migration engages in the specialized or custom system migration technologies. The App Development includes development of mobile and tablet applications. The company was founded on December 18, 2001 and is headquartered in South Yarra, Australia. | Technology Services |
Priority Processing Systems Pty Ltd.
Priority Processing Systems Pty Ltd. Regional BanksFinance Part of Spenda Ltd., Priority Processing Systems Pty Ltd. offers financial transaction based services to consumers and retailers. Priority Processing Systems was acquired by Motopia Ltd. on March 07, 2013 for $1.03 million. | Finance |
CU2 Global Pty Ltd.
CU2 Global Pty Ltd. Packaged SoftwareTechnology Services Part of Spenda Ltd., CU2 Global Pty Ltd. is an Australian company that helps organizations address and manage the complexity of a changing digital world. The company is based in Auburn, Australia. CU2 Global has been providing legacy application migration services to a clientele for over a decade. CU2 Global was acquired by Motopia Ltd. on November 07, 2014 for $0.09 million. | Technology Services |
Elk OrthoBiologics Ltd.
Elk OrthoBiologics Ltd. BiotechnologyHealth Technology Elk OrthoBiologics Ltd. is an Australian biotechnology company developing a minimally invasive biologic therapy for repairing aseptically loosened hip and knee prosthetic implants. It offers Gene Directed Enzyme Prodrug Therapy (GDEPT), a technology where a short acting gene therapy is used to convert a small molecule prodrug into an active drug within a target tissue. It is also a onetime treatment designed to destroy an unwanted tissue. The company is headquartered in Hawthorn East, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Lindsay Brown
- Expérience